Madeline Colli is the Associate Editor for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

Madeline Colli

Articles

Ireland opens up their first medical cannabis clinic.

Medicann Pioneers Ireland's First Comprehensive Medical Cannabis Clinic, Expanding Access and Treatment Options

The University of Buffalo has received a grant from the NIH National Cancer Institute to research cannabis’s medicinal effect on cancer immunotherapy treatment.

NIH National Cancer Institute Grant Awarded to Help Study Cannabis’s Medicinal Effect on Cancer Immunotherapy Treatment

A survey conducted by EO Care, Inc., showed that Americans would be more inclined to use cannabis to treat their health conditions if they were guided by a clinician.

EO Survey Shows 65% of Americans Would Use Cannabis If Guided by A Clinician

Cannabis Patients Pacific Northwest (CPPNW) co-founders, David Benedicktus and Jeremy Robbins, discuss what changes need to be made to the cannabis industry to allow it to thrive. 

What Needs to Change in the Cannabis Industry: Thoughts from CPPNW

Aurélien Rousseau, the Minister for Health of France, promises to roll out medical cannabis access to patients throughout the country.

Health Minister of France Strives to Maintain Medical Cannabis Access for Patients

Two senate bills, SB 302 and SB 700, were passed to California Governor Newsom where they were signed into law, expanding cannabis rights for both patients and employees.

California Expands Cannabis Rights for Patients and Employees

The ANA has formally announced their recognition of cannabis nursing as a specialty nursing practice.

Historic Milestone: American Nurses Association Recognizes Cannabis Nursing as a Specialized Practice

On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way for reform, industry expansion, and research opportunities.

Shifting Tides: US Department of Health and Human Services Recommends Cannabis Rescheduling from Schedule I to Schedule III

Don't miss these exciting speakers in the medical and psychedelics tracks at Cannabis Science Conference Fall taking place September 21-22, 2023 in Providence, Rhode Island!

Cannabis Science Conference Fall: Medical and Psychedelics Agenda 

Meg is the Group Editorial Director for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

Dr. Peter Grinspoon, a primary care doctor at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and a 25-year cannabis specialist, will be a keynote speaker at the upcoming Cannabis Science Conference Fall taking place September 21-22, 2023 in Providence, Rhode Island. Here, Dr. Grinspoon shares his background and interest in medical cannabis as well some policies he’d like to see changed in the future. 